Clincosm LogoSign in Get a demo

SARS-CoV-2

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

SARS-CoV-2 Trial in Canada, United States (mRNA-1273, Placebo)

Recruiting
  • SARS-CoV-2
  • mRNA-1273
  • +2 more
  • Birmingham, Alabama
  • +89 more
Oct 7, 2022

SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273
  • Mesa, Arizona
  • +14 more
Aug 31, 2022

Sars-CoV-2, Covid19 Trial in Brazil, United States (BLD-2660)

Completed
Has Results
  • Sars-CoV-2
  • Covid19
  • Irvine, California
  • +34 more
Apr 1, 2022

SARS-CoV-2, Covid-19 Trial in Philadelphia (Sirolimus 1 MG/ML, Placebo)

Withdrawn
  • SARS-CoV-2
  • Covid-19
  • Sirolimus 1 MG/ML
  • Placebo
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Dec 2, 2021

SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

Active, not recruiting
  • SARS-CoV-2
  • COVID-19
  • Sample collection
  • Birmingham, Alabama
  • +52 more
Sep 3, 2021

Cytokine Storm, SARS-CoV-2 Trial in Philadelphia (Doxycycline, Placebo)

Withdrawn
  • Cytokine Storm
  • SARS-CoV-2
  • Philadelphia, Pennsylvania
    Temple University Hospital
Apr 13, 2021